Mean Maternal Age (years) |
32.7 (5.3) |
31.1 (6.1) |
MD 0.8
(0.2 to 1.5) |
31.9 (5.7) |
Non-white ethnicity n (%) |
60 (33.0%) |
44 (27.8%) |
RR
1.18 (0.85-1.64) |
104 (30.6%) |
Multiparous, n (%) |
90 (49.5) |
83 (52.2) |
RR 0.95 (0.77 to
1.17) |
173 (50.7) |
Body mass index, Kg/m2 |
30.2 (6.5) |
30.1
(7.9) |
MD 0.1 (-0.7 to 0.8) |
30.2 (7.2) |
Maternal History of Pre-eclampsia n (%) |
28 (31.1%) |
29
(34.9%) |
RR 0.84 (0.53 to 1.35) |
57 (32.9%) |
Chronic Hypertension n (%) |
20 (11.0%) |
25 (15.7%) |
RR
0.70 (0.40 to 1.21) |
45 (13.2%) |
Chronic Kidney Disease n (%) |
3 (1.6%) |
2 (1.3%) |
RR 1.31
(0.22 to 7.74) |
5 (1.5%) |
Aspirin use |
75 (41.4%) |
68 (42.8%) |
RR 0.97 (0.75 to
1.24) |
43 (42.1%) |
Gestation at enrolment (weeks)
Mean (SD)
|
35.4 (0.86)
|
35.5 (0.89)
|
MD -0.1 (-0.2 to 0.04)
|
35.4 (0.88)
|
Maternal BP 48 hours prior to enrolment (mmHg) (SD)
Systolic
Diastolic
|
153 (15)
94 (10)
|
155 (16)
95 (11)
|
MD -0.8 (-2.4 to 0.8)
MD -0.3 (-1.4 to 0.8)
|
154 (15)
94 (10)
|
Highest urinary PCR
Number with measurement
Mean (SD)
|
177
145 (238)
|
156
189 (337)
|
MD -22 (-54 to 10)
|
333
166 (289)
|
Suspected FGR on ultrasound |
22 (12.1%) |
25 (15.7%) |
RR
0.77 (0.45 to 1.31) |
47/341 (13.8%) |
Maternal PlGF (pg/mL)
Number with measurement
Mean (SD)
Median (IQR)
|
178
37.1 (134.1)
12.0 (12.0-18.6)
|
157
43.6 (146.7)
12.6 (12.0-24.1)
|
MD -3.3 (-18.5 to 11.9)
|
335
40.16 (140.00)
12.0 (12.0-20.6)
|
PlGF ≥ 100 pg/mL |
9 (5.1%) |
7 (4.5%) |
RR 1.60 (0.64 to
4.02) |
18 (5.8%) |
PlGF 12-100 pg/mL |
67 (43.5%) |
75 (47.8%) |
RR 0.91 (0.71
to 1.16) |
142 (45.7%) |
PlGF <12 pg/mL |
76 (49.4%) |
75 (47.8%) |
RR 1.03
(0.82 to 1.30) |
151 (48.6%) |